On ECHEMI
Home > Drugs > Vitamin D2 Calcium Fructose Injection

Vitamin D2 Calcium Fructose Injection

Function and Efficacy

Vitamin D2 must be converted by both the liver and kidneys to become biologically active vitamin D3, which regulates calcium and phosphorus metabolism. In this conversion process, only a portion of vitamin D2 is ultimately converted into vitamin D3. Therefore, the biological activity of vitamin D2 is far inferior to that of vitamin D3.

Ingredients

Calcium fructose, vitamin D2, water for injection.

Name Description Content CAS NO. Manufacturer
CALCIUM LEVULINATEIngredients

Vitamin D2 must be converted by both the liver and kidneys to become biologically active vitamin D3, which regulates calcium and phosphorus metabolism. In this conversion process, only a portion of vitamin D2 is ultimately converted into vitamin D3. Therefore, the biological activity of vitamin D2 is far inferior to that of vitamin D3.

More
591-64-0 2
Vitamin D2Ingredients

It must be converted by both the liver and kidneys to become biologically active vitamin D3, which plays a role in regulating calcium and phosphorus metabolism. In this conversion process, only a portion of vitamin D2 is ultimately converted into vitamin D3. Therefore, the biological activity of vitamin D2 is far inferior to that of vitamin D3.

More
50-14-6 14

Appearance

This product is a white translucent emulsion.

Indication

Used to prevent and treat calcium deficiency, such as osteoporosis and rickets.

Usage and Dosage

For children, inject intramuscularly or subcutaneously, 1 ml each time, once a day or every other day. Shake well before use. Do not use if water-oil separation occurs.

Adverse Reactions

1. With normal usage and dosage, adverse reactions rarely occur. Gastrointestinal reactions such as loss of appetite and vomiting are occasionally seen. 2. Excessive intake of vitamin D in a short period of time or long-term use of large amounts of vitamin D can lead to severe poisoning reactions. For example, infants and young children taking 200,000 to 400,000 units per day for several weeks or months can cause severe toxic reactions.

Precautions

1. Contraindicated for patients with calcemia, hypervitaminosis D, hyperphosphatemia and renal rickets. 2. Use with caution in patients with arteriosclerosis, heart failure and hypercholesterolemia. 3. Use with caution in patients with high sensitivity to vitamin D. 4. Use with caution in patients with renal failure.

Special Population Medication

Precautions for children: Infants who are fully breastfed are prone to vitamin D deficiency, especially infants of mothers with dark skin. Infants have great differences in sensitivity to vitamin D, and some infants are very sensitive to small doses of vitamin D. The product of serum calcium and phosphorus concentrations [ca] × [P] (mg/dl) should not be greater than 58. Long-term use of 1800 units of vitamin D2 per day in children may cause growth stagnation. Precautions for pregnancy and lactation: Pregnant and lactating women generally need to supplement calcium, but the usage and dosage should be in accordance with the doctor's advice. There are currently no animal and human experiments on the effects of calcium on the fetus. Pregnant and lactating women should use vitamin D preparations with caution. Pregnant women with hypercalcemia may be sensitive to vitamin D, so attention should be paid to dose adjustment. Functionally, it can inhibit parathyroid activity, resulting in special facial features, mental retardation and hereditary aortic arch stenosis in infants. Precautions for the elderly: The elderly may have reduced secretion of active vitamin D, namely vitamin D3, and reduced intestinal absorption of calcium, so the oral dose should be increased accordingly.

Drug Interactions

Not yet clear

Storage

Keep away from light, tightly closed, in a cool place.

Packaging Specification

1 ml: Calcium 0.5 mg + Vitamin D2 0.125 mg

Validity Period

Tentative 24 months

Manufacturer

Jiangxi Gannan Haixin Pharmaceutical Co., Ltd.

  • Founded in:

    2001-12-31
  • Address:

    No. 209, Lakeside Avenue, Ganzhou Economic and Technological Development Zone, Ganzhou City, Jiangxi Province
  • Tax NO.:

    91360700733914344A
  • Registered Funds:

    100 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.